Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Hartmut Beck, Tobias Thaler, Daniel Meibom, Mark Meininghaus, Hannah Jörißen, Lisa Dietz, Carsten Terjung, Michaela Bairlein, Clemens-Jeremias von Bühler, Sonja Anlauf,

Journal of Medicinal Chemistry · 2020 · 31 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

efficacy in a preclinical animal model of lung fibrosis, thus paving the way for a new treatment option in IPF.

References

38